Farmacia hospitalaria
Especialidad
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitari de Bellvitge (9)
2024
-
Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain
BMC Geriatrics, Vol. 24, Núm. 1
2021
-
Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study
Scientific reports, Vol. 11, Núm. 1, pp. 5375
-
Consumption of ultra-processed foods and drinks and colorectal, breast, and prostate cancer
Clinical Nutrition, Vol. 40, Núm. 4, pp. 1537-1545
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
-
Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study
Scientific Reports, Vol. 11, Núm. 1
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252
2020
-
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536
2019
-
Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
Therapeutic Advances in Gastroenterology, Vol. 12